AN2 Therapeutics
PublicAN2 Therapeutics is now publicly traded
The data on this page reflects AN2 Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Mar 10, 2026
Total Funding Raised
$40M
Company Overview
AN2 Therapeutics operates in Healthcare and is based in Menlo Park, California. It has raised $40M.
AN2 Therapeutics (NAS: ANTX) is a biopharmaceutical company focused on developing innovative treatments for rare and serious infectious diseases with significant unmet medical needs.
Sector
Healthcare
AI Layer
Non-AI
AN2 Therapeutics Comparables
Compare AN2 Therapeutics with similar companies based on industry and business-model similarity.
No comparables are published for AN2 Therapeutics. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
AN2 Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Mar 10, 2026 |
For institutional investors. Book with your work email.
AN2 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coastlands Capital LP | Follow-on Offering |
| Commodore Capital | Follow-on Offering |
| Vivo Capital | Follow-on Offering |
AN2 Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.